Is E-therapeutics Plc (ETXPF) a Buy, Sell, or Hold?
OTC : ETXPF
E-therapeutics Plc
$0.13 USD
$0 (0.0%)
- Volume
- 30
- Average Volume
- 993
- Market Capitalization
- $75.96M
- P/E Ratio
- -4.71
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.13
- Year Low
- $0.13
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.87
Company Overview
OTC
Ahmad Ali Mortazavi
Biotechnology
Healthcare
ETXPF
39
GB
USD
Liquidity Metrics
0.03
8.87
8.87
7.77
0.00
Sales & Valuation
-$
177.32
2.39
-5.06
-0.02
Profitability
-$0.0201
-$14.87M
-3511.32%
-4113.52%
-40.58%
-44.72%
P/E Metrics
-4.71
-0.05
-0.05
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
10.46
0/9
$34.42M
$38.19M
$2.12M
-$31.7M
Key Metrics (TTM)
$36.43M
114.57
-2.65
8.87
-40.58%
-51.86%
-21.23%
-19.76%
0 days
Company Executives
| Name | Title |
|---|---|
| Laura Roca-Alonso | Chief Operating & Business Officer |
| Ahmad Ali Mortazavi | Chief Executive Officer & Director |
| Alan Whitmore | Chief Scientific Officer |
| Ankit Sharma | Head of Software Engineering |
| Graham Craggs | Head of Therapeutic Discovery |
| Timothy Bretherton | Chief Financial Officer, Director of Finance & Operations and Company Secretary |
Poll Results
No votes yet today — be the first to share your view!
About E-therapeutics Plc (OTC:ETXPF) Stock
E-therapeutics Plc is a UK-based company focused on drug discovery. The core of its work involves a sophisticated computational platform that employs in-silico screening and unique network models to identify and predict which compounds or biological targets can effectively alter relevant biological processes. Furthermore, the company is advancing an RNA interference (RNAi) platform designed for highly specific gene silencing. Founded in 2001, E-therapeutics Plc operates from its headquarters in London, United Kingdom. ...
Frequently Asked Questions
-
What is the current E-therapeutics Plc (ETXPF) stock price?
-
E-therapeutics Plc(OTC:ETXPF) stock price is $0.13 in the last trading session. During the trading session, ETXPF stock reached the peak price of $0.13 while $0.13 was the lowest point it dropped to. The percentage change in ETXPF stock occurred in the recent session was 0.0% while the dollar amount for the price change in ETXPF stock was $0.
-
ETXPF's industry and sector of operation?
-
The OTC listed ETXPF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ETXPF?
-
Laura Roca-Alonso | Chief Operating & Business Officer
Ahmad Ali Mortazavi | Chief Executive Officer & Director
Alan Whitmore | Chief Scientific Officer
Ankit Sharma | Head of Software Engineering
Graham Craggs | Head of Therapeutic Discovery -
How many employees does ETXPF have?
-
Number of ETXPF employees currently stands at 39. ETXPF operates from 4 Kingdom Street, London, None W2 6BD, GB.
-
Link for ETXPF official website?
-
Official Website of ETXPF is: https://www.etherapeutics.co.uk
-
How do I contact ETXPF?
-
ETXPF could be contacted at phone #44 20 4551 8888 and can also be accessed through its website. ETXPF operates from 4 Kingdom Street, London, None W2 6BD, GB.
-
How many shares of ETXPF are traded daily?
-
The average number of ETXPF shares traded daily for last 3 months was 993.
-
What is the market cap of ETXPF currently?
-
The market value of ETXPF currently stands at $75.96M with its latest stock price at $0.13